BSX

Boston Scientific

Health Care

Health Care Equipment

Marlborough, Massachusetts

Balance Sheet 33 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$414.0M	$865.0M	$928.0M	$1.9B	$1.7B
Assets - AccountsReceivable	$218.0M	$220.0M	$218.0M	$216.0M	$210.0M
Assets - Inventories	$2.8B	$2.5B	$1.9B	$1.6B	$1.4B
Assets - PrepaidExpensesAndOtherCurrentAssets	$831.0M	$621.0M	$731.0M	$799.0M	$751.0M
Assets - TotalCurrentAssets	$6.9B	$6.5B	$5.8B	$6.3B	$6.7B
Assets - Property,PlantAndEquipment	$3.3B	$2.9B	$2.4B	$2.3B	$2.1B
Assets - Goodwill	$17.1B	$14.4B	$12.9B	$12.0B	$10.0B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$6.7B	$6.0B	$5.9B	$6.1B	$5.9B
Assets - OperatingLeaseAssets	$449.0M	$439.0M	$386.0M	$435.0M	$458.0M
Assets - DeferredTaxAssets	$3.7B	$3.8B	$4.0B	$3.9B	$3.8B
Assets - LongTermInvestments	$278.0M	$219.0M	$188.0M	$259.0M	$319.0M
Assets - OtherNoncurrentAssets	$1.8B	$1.5B	$1.5B	$1.4B	$1.9B
Assets - TotalNoncurrentAssets	$27.5B	$23.7B	$21.7B	$20.8B	$18.4B
Assets - TotalAssets	$39.4B	$35.1B	$32.5B	$32.2B	$30.8B
Liabilities - AccountsPayable	$960.0M	$942.0M	$862.0M	$794.0M	$513.0M
Liabilities - AccruedLiabilities	$2.8B	$2.6B	$2.2B	$2.4B	$2.2B
Liabilities - ContractLiabilitiesCurrent	$635.0M	$577.0M	$509.0M	$484.0M	$395.0M
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$1.8B	$531.0M	$20.0M	$261.0M	$13.0M
Liabilities - OperatingLeaseLiabilitiesCurrent	$81.0M	$76.0M	$61.0M	$71.0M	—
Liabilities - OtherCurrentLiabilities	$887.0M	$814.0M	$761.0M	$783.0M	$958.0M
Liabilities - TotalCurrentLiabilities	$6.4B	$4.9B	$3.8B	$4.3B	$3.7B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$401.0M	$390.0M	$347.0M	$389.0M	$401.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$155.0M	$134.0M	$144.0M	$310.0M	$330.0M
Liabilities - ContingentConsiderationLiabilityNoncurrent	$108.0M	$100.0M	$75.0M	$197.0M	$171.0M
Liabilities - OtherNoncurrentLiabilities	$1.9B	$2.0B	$2.0B	$2.2B	$2.3B
Equity - PreferredStock	$0	$0	$0	$0	$0
Equity - CommonStock	$17.0M	$17.0M	$17.0M	$17.0M	$17.0M
Equity - AdditionalPaidInCapital	$21.1B	$20.6B	$20.3B	$20.0B	$19.7B
Equity - RetainedEarnings(deficit)	$2.7B	$819.0M	$-750.0M	$-1.4B	$-2.4B
Equity - TreasuryStock	$2.3B	$2.3B	$2.3B	$2.3B	$2.3B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$275.0M	$49.0M	$269.0M	$263.0M	$207.0M
Equity - TotalLiabilitiesAndStockholdersEquity	$39.4B	$35.1B	$32.5B	$32.2B	$30.8B

Income Statement 22 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/Sales	$16.7B	$14.2B	$12.7B	$11.9B	$9.9B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold/CostOfSales	$5.3B	$4.3B	$4.0B	$3.7B	$3.5B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$6.0B	$5.2B	$4.5B	$4.4B	$3.8B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$856.0M	$828.0M	$803.0M	$741.0M	$789.0M
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$412.0M	$367.0M	$333.0M	$352.0M	$333.0M
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$16.0M	$69.0M	$24.0M	$40.0M	$52.0M
IncomeStatement - OtherIncomeExpense - GrossProfit	$11.5B	$9.9B	$8.7B	$8.2B	$6.4B
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$2.6B	$2.3B	$1.6B	$1.2B	$-80.0M
IncomeStatement - OtherIncomeExpense - InterestExpense	$305.0M	$265.0M	$470.0M	$341.0M	$361.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnExtinguishmentOfDebt	$0	$0	$-194.0M	$0	—
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-321.0M	$-358.0M	$-508.0M	$218.0M	$362.0M
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$2.3B	$2.0B	$1.1B	$1.1B	$-79.0M
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$436.0M	$393.0M	$443.0M	$36.0M	$2.0M
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$0	$0	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$1.8B	$1.6B	$698.0M	$1.0B	$-82.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$1.9B	$1.6B	$642.0M	$985.0M	$-115.0M
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare(net)	$1	$1	$0	$1	$-0
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare(net)	$1	$1	$0	$1	$-0
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$1.5B	$1.5B	$1.4B	$1.4B	$1.4B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$1.5B	$1.5B	$1.4B	$1.4B	$1.4B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$2.1B	$1.4B	$704.0M	$1.1B	$-145.0M

Cash Flow Statement 19 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - DepreciationAndAmortization	$412.0M	$367.0M	$333.0M	$352.0M	$333.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$266.0M	$233.0M	$220.0M	$194.0M	$170.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-90.0M	$73.0M	$-7.0M	$-142.0M	$-85.0M
CashFlow - OperatingActivities - ProvisionForDoubtfulAccounts	$41.0M	$50.0M	$35.0M	$28.0M	$49.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$822.0M	$1.0B	$286.0M	$1.0B	$-298.0M
CashFlow - OperatingActivities - CashFromOperatingActivities(continuingOperations)	$3.4B	$2.5B	$1.5B	$1.9B	$1.5B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e)	$790.0M	$711.0M	$588.0M	$554.0M	$376.0M
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$4.6B	$1.8B	$1.5B	$2.3B	$3.0M
CashFlow - InvestingActivities - ProceedsFromDivestitureOfBusinesses/assets	$0	$0	$5.0M	$826.0M	$15.0M
CashFlow - InvestingActivities - OtherInvestingActivities	$-20.0M	$-30.0M	$-70.0M	$-82.0M	$-87.0M
CashFlow - InvestingActivities - CashFromInvestingActivities(continuingOperations)	$-5.7B	$-2.6B	$-2.0B	$-1.6B	$-411.0M
CashFlow - FinancingActivities - PaymentOfDividends	$0	$28.0M	$55.0M	$55.0M	$28.0M
CashFlow - FinancingActivities - PaymentForContingentConsideration(financing)	$131.0M	$39.0M	$335.0M	$15.0M	$49.0M
CashFlow - FinancingActivities - CashFromFinancingActivities(continuingOperations)	$1.8B	$5.0M	$-548.0M	$-95.0M	$293.0M
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-11.0M	$-4.0M	$-9.0M	$-6.0M	$-2.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-450.0M	$-70.0M	$-1.0B	$173.0M	$1.4B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$250.0M	$259.0M	$450.0M	$338.0M	$359.0M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$117.0M	$123.0M	$43.0M	$68.0M	$202.0M

Boston Scientific

Balance Sheet 33 Accounts • 5 Years

Income Statement 22 Accounts • 5 Years

Cash Flow Statement 19 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History